HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 3
Terminated
- Conditions
- Prostate Cancer MetastaticCastration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Hinova Pharmaceuticals USA, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT03850795
- Locations
- 🇵🇱
NZOZ Centrum Urologiczne Sp zoo, Mysłowice, Slaskie, Poland
🇫🇷Hopital d'Instruction des Armées de Begin, Saint-Mandé, France
🇳🇱Antonius Ziekenhuis, Sneek, Friesland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath